Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 20/20 | 1.00 |
| ▸ | MMP12 | P39900 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4983873 | 0.89 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4347482 | 0.84 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4351324 | 0.84 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4981002 | 0.83 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4980986 | 0.81 | ADAMTS5 (0.84) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4352205 | 0.80 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL22571290 | 0.80 | ADAMTS5 (0.72) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4354284 | 0.78 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL24571121 | 0.78 | ADAMTS5 (0.78) | ADAMTS5MMP12ALDH1A1LMNAHPGD | |
| SCHEMBL4983286 | 0.78 | ADAMTS5 (1.00) | ADAMTS5MMP12ALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080125469-A1 | Thiadiazole compounds and methods of use thereof | WYETH (US) | 2008-05-29 | — | — | US | claimed |
| EP-2032584-A2 | THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | Wyeth (US) | 2009-03-11 | — | — | EP | disclosed |
| US-20080125469-A1 | Thiadiazole compounds and methods of use thereof | WYETH (US) | 2008-05-29 | — | — | US | disclosed |
| WO-2007146138-A2 | THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | WYETH (US) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125469-A1 | Thiadiazole compounds and methods of use thereof | ADAMTS5, ADAMTS1, TIMP3 | ADAMTS5 1/4885MMP12 26/4885ALDH1A1 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.